Aandeel A041910 POLARIS AI PHARMA CORP.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen Polaris AI Pharma Corp.

Aandelen

A041910

KR7041910001

slotkoers Korea S.E.
Andere beurzen
 00:00:00 14-06-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
8.420 KRW -0,71% Intraday-grafiek van Polaris AI Pharma Corp. -1,98% +22,03%
27/03 Polaris Office Corp. (KOSDAQ:A041020), Leenos Corp. (KOSDAQ:A039980), Sewon Co.,Ltd (KOSDAQ:A234100) en POLARIS UNO, Inc. (KOSDAQ:A114630) hebben de overname afgerond van 20% van de aandelen in EstechPharma Co. (KOSDAQ:A041910) van Jae-cheol Kim en Seon-hee Bae. CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
Polaris AI Pharma Corp. announced that it has received KRW 5.1536 billion in funding
Polaris Office Corp., Leenos Corp., Sewon Co.,Ltd and POLARIS UNO, Inc. completed the acquisition of 20% stake in EstechPharma Co., Ltd. from Jae-cheol Kim and Seon-hee Bae.
Polaris Office Corp., Leenos Corp., Sewon Co.,Ltd and POLARIS UNO, Inc. agreed to acquire 20% stake in EstechPharma Co., Ltd. from Jae-cheol Kim and Seon-hee Bae for KRW 40 billion.
Polaris AI Pharma Corp. announced that it expects to receive KRW 5.1536 billion in funding
EstechPharma Co., Ltd.(KOSDAQ:A041910) dropped from S&P Global BMI Index
Vivozon Inc. announced that it has received KRW 100 billion in funding from TELCON RF PHARMACEUTICAL. Inc., EstechPharma Co., Ltd.
Vivozon, Inc. announced that it expects to receive KRW 100 billion in funding from TELCON RF PHARMACEUTICAL. Inc., EstechPharma Co., Ltd.
Tranche Update on EstechPharma Co., Ltd.'s Equity Buyback Plan announced on December 12, 2016.
EstechPharma Co., Ltd.'s Equity Buyback announced on December 12, 2016, has expired with 106,086 shares, representing 0.94% for KRW 1,054.08 million.
Tranche Update on EstechPharma Co., Ltd.'s Equity Buyback Plan announced on December 12, 2016.
EstechPharma Co., Ltd. authorizes a Buyback Plan.
EstechPharma Co., Ltd. announces an Equity Buyback for KRW 3,000 million worth of its shares.
EstechPharma Co., Ltd.(KOSDAQ:A041910) added to S&P Global BMI Index
Vivozon, Inc. announced that it has received KRW 2 billion in funding from EstechPharma Co., Ltd.
Vivozon, Inc. announced that it expects to receive KRW 2 billion in funding from EstechPharma Co., Ltd.
Tranche Update on EstechPharma Co., Ltd.'s Equity Buyback Plan announced on December 5, 2013.
EstechPharma Co., Ltd.'s Equity Buyback announced on December 5, 2013 has closed with 110,619 shares for KRW 950.06 million.
EstechPharma Co., Ltd. announces an Equity Buyback for 110,619 shares, for KRW 1,000 million.
EstechPharma Co., Ltd. authorizes a Buyback Plan.
Korea Securities Finance Corporation acquired 4.06% stake in EstechPharma Co., Ltd..
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers A041910
  4. Nieuws Polaris AI Pharma Corp.
  5. Andere talen